Total Payments
$6,120
2024 Payments
$765.96
Companies
31
Transactions
400
Medicare Patients
1,799
Medicare Billing
$158,024
Payment Breakdown by Category
Food & Beverage$6,108 (99.8%)
Education$12.04 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,108 | 398 | 99.8% |
| Education | $12.04 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $885.63 | 44 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $831.89 | 47 | $0 (2024) |
| ABBVIE INC. | $546.25 | 33 | $0 (2024) |
| PFIZER INC. | $440.74 | 28 | $0 (2024) |
| Lilly USA, LLC | $400.50 | 29 | $0 (2024) |
| Amgen Inc. | $392.49 | 23 | $0 (2024) |
| Novo Nordisk Inc | $385.38 | 32 | $0 (2024) |
| GlaxoSmithKline, LLC. | $378.29 | 29 | $0 (2024) |
| Merck Sharp & Dohme LLC | $361.37 | 23 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $231.22 | 23 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $765.96 | 38 | AstraZeneca Pharmaceuticals LP ($166.03) |
| 2023 | $652.12 | 37 | ABBVIE INC. ($217.19) |
| 2022 | $578.14 | 31 | Boehringer Ingelheim Pharmaceuticals, Inc. ($255.23) |
| 2021 | $972.52 | 56 | Boehringer Ingelheim Pharmaceuticals, Inc. ($183.15) |
| 2020 | $933.15 | 61 | Boehringer Ingelheim Pharmaceuticals, Inc. ($107.88) |
| 2019 | $802.47 | 59 | AstraZeneca Pharmaceuticals LP ($176.01) |
| 2018 | $157.57 | 12 | AstraZeneca Pharmaceuticals LP ($48.96) |
| 2017 | $1,258 | 106 | Lilly USA, LLC ($196.37) |
All Payment Transactions
400 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: VACCINE | ||||||
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: DIABETES | ||||||
| 11/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: PSYCHIATRY | ||||||
| 09/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Obesity | ||||||
| 08/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Inflammation | ||||||
| 08/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Respiratory | ||||||
| 08/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: RESPIRATORY | ||||||
| 08/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Biological | ||||||
| 08/01/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.81 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: RESPIRATORY | ||||||
| 07/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Respiratory | ||||||
| 07/12/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.54 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.35 | General |
| Category: DIABETES | ||||||
| 07/02/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.91 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Inflammation | ||||||
| 06/11/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Diabetes | ||||||
| 06/06/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Respiratory | ||||||
| 05/01/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: VACCINE | ||||||
| 04/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $31.10 | General |
| Category: NEUROSCIENCE | ||||||
| 04/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 548 | 717 | $96,401 | $50,294 |
| 2022 | 9 | 435 | 534 | $77,052 | $42,005 |
| 2021 | 6 | 339 | 412 | $58,815 | $34,462 |
| 2020 | 10 | 477 | 570 | $59,752 | $31,264 |
Total Patients
1,799
Total Services
2,233
Medicare Billing
$158,024
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 168 | 317 | $60,230 | $26,808 | 44.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 95 | 95 | $14,250 | $11,911 | 83.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 43 | 43 | $4,085 | $3,400 | 83.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 58 | $6,960 | $3,059 | 43.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 12 | 13 | $5,070 | $2,596 | 51.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 95 | 95 | $2,375 | $1,675 | 70.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 12 | $840.00 | $435.80 | 51.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 15 | 16 | $1,296 | $178.40 | 13.8% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 30 | 35 | $875.00 | $107.89 | 12.3% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 16 | 18 | $270.00 | $70.92 | 26.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 12 | 15 | $150.00 | $51.15 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 131 | 220 | $38,220 | $18,097 | 47.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 63 | 63 | $9,450 | $7,961 | 84.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 43 | 44 | $9,680 | $4,936 | 51.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 62 | 62 | $5,890 | $4,794 | 81.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 14 | 15 | $5,450 | $3,036 | 55.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 46 | $5,310 | $2,272 | 42.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 38 | 38 | $950.00 | $662.32 | 69.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 15 | 17 | $1,377 | $175.92 | 12.8% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 25 | 29 | $725.00 | $71.06 | 9.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 113 | 171 | $28,215 | $13,909 | 49.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 60 | 60 | $7,900 | $7,802 | 98.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 60 | 61 | $13,420 | $7,094 | 52.9% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 46 | 46 | $4,370 | $3,832 | 87.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 29 | 34 | $3,910 | $1,708 | 43.7% |
About Dr. Samuel Minor, MD
Dr. Samuel Minor, MD is a Family Medicine healthcare provider based in Petoskey, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1356520084.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel Minor, MD has received a total of $6,120 in payments from pharmaceutical and medical device companies, with $765.96 received in 2024. These payments were reported across 400 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($6,108).
As a Medicare-enrolled provider, Minor has provided services to 1,799 Medicare beneficiaries, totaling 2,233 services with total Medicare billing of $158,024. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Petoskey, MI
- Active Since 10/30/2007
- Last Updated 10/30/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1356520084
Products in Payments
- FARXIGA (Drug) $518.43
- JARDIANCE (Drug) $424.21
- STIOLTO RESPIMAT (Drug) $277.84
- ELIQUIS (Drug) $261.99
- UBRELVY (Drug) $225.51
- QULIPTA (Drug) $204.79
- XARELTO (Drug) $199.26
- Ozempic (Drug) $194.63
- REXULTI (Drug) $187.48
- TRADJENTA (Drug) $173.27
- TRELEGY ELLIPTA (Drug) $167.13
- Aimovig (Biological) $166.62
- Victoza (Drug) $130.39
- CHANTIX (Drug) $128.85
- ENTRESTO (Drug) $118.49
- EMGALITY (Drug) $117.69
- BEVESPI AEROSPHERE (Drug) $112.66
- EVENITY (Biological) $111.72
- Otezla (Drug) $96.38
- TRULICITY (Drug) $93.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Petoskey
Scott Hotchkiss, Md, MD
Family Medicine — Payments: $7,617
Family Medicine $7,617
Dr. Joshua Saur, D.o, D.O
Family Medicine — Payments: $3,091
Family Medicine $3,091
Dr. Martin Jankowski, Do, DO
Family Medicine — Payments: $1,913
Family Medicine $1,913
Todd Decker, Md, MD
Family Medicine — Payments: $1,113
Family Medicine $1,113
Dr. Todd Sheperd, Md, MD
Family Medicine — Payments: $549.27
Family Medicine $549.27
Terry Samuels, M.d, M.D
Family Medicine — Payments: $266.22
Family Medicine $266.22